Oncolytics Biotech Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ONCY research report →
Companywww.oncolyticsbiotech.com
Oncolytics Biotech Inc. , a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies.
- CEO
- Jared Kelly
- IPO
- 2001
- Employees
- 28
- HQ
- Calgary, AB, CA
Price Chart
Valuation
- Market Cap
- $82.98M
- P/E
- -3.65
- P/S
- 0.00
- P/B
- -24.88
- EV/EBITDA
- -3.09
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 5132.04%
- ROIC
- -1067.73%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-39,461,086 · -24.44%
- EPS
- $-0.41 · 0.00%
- Op Income
- $-39,414,434
- FCF YoY
- -1.44%
Performance & Tape
- 52W High
- $1.51
- 52W Low
- $0.33
- 50D MA
- $0.95
- 200D MA
- $1.04
- Beta
- 1.03
- Avg Volume
- 1.09M
Get TickerSpark's AI analysis on ONCY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 11, 26 | Parsons James T. | buy | 10,000 |
| Mar 12, 26 | Kelly Jared | buy | 5,050 |
| Feb 12, 26 | Kelly Jared | buy | 29,500 |
| Feb 11, 26 | Kelly Jared | buy | 5,600 |
| Feb 12, 26 | Look Kirk | buy | 12,000 |
| Feb 12, 26 | Pisano Wayne | buy | 30,000 |
| Feb 12, 26 | Heineman Thomas Charles | buy | 12,132 |
| Feb 12, 26 | Brown Deborah Margaret | buy | 25,000 |
| Feb 12, 26 | Hagerman Allison | buy | 10,000 |
| Feb 12, 26 | Seizinger Bernd R. | buy | 40,000 |
Our ONCY Coverage
We haven't published any research on ONCY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ONCY Report →